TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Variability of stiffness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of patients going to operating room for surgical resection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immunity level before vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Delivery or Treatment Failure
Endpoint domain: Mortality/survival
Primary endpoint: Number of Neonates With Any Diagnosis From the Neonatal Morbidity and Mortality Composite Component
Endpoint domain: Mortality/survival
Primary endpoint: complete bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Average Sleep Latency Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Instances of child's disruptive behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Red Blood Cell (RBC) Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pedobarographic Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of PF-00184562
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum concentration (Cmax) of PF-00184562
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to obtain maximum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-value preoperative investigations received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Metabolic Acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum ketone body concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postural Assessment Scale for Stroke Patients (PASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance Evaluation Systems Test (BESTtest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Get up and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of CI-8993
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of intensity of bladder bother symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in citrate concentration in circuit after AV port reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in post-filter ionised Ca after AV port reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in clearance after AV port reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic value of new biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cause Specific Survival (CSS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mother's anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Mother's depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of spermatozoa in the ejaculate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Frequency of Urge Urinary Incontinence Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with post-surgical reactions
Endpoint domain: Adverse events/effects
Primary endpoint: vaginal concentrations of innate immunity markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with newly onset of symptomatic venous thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Levels of C-reactive proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Average Forced Expiratory Volume in 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bone Marrow Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: incidence of adverse events/adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of cystic fibrosis exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrolyte imbalance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported outcome score - IKDC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Area Under the Curve for Total Viable Counts of Bacteria in Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of initial delayed graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VAS scores during resting and forceful respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients having at least one handgrip strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Global Impression Severity scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance to ERAS program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of formula tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage decline in IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pharmacokinetic parameters for tamsulosin HCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Recurrence of AF lasting longer than 15 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serotonin biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants able to complete perfusion scan acquisition at the time of treatment-planning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants able to complete perfusion scan acquisition within 48 hours of SABR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants able to complete perfusion scan acquisition in follow-up up to 4 months after SABR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to decrease of BKV plasma viral load by 1 log
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to first decrease of BKV plasma viral load to less than LLOQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 10 meter walk test (sec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Renal Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in urinary TIMP-2*IGFBP7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: SVR Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms and functional limitations
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intake in kcal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Localization of the epileptogenic zone (EZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Indicated Grade Change From Baseline in the EC Grading Scale at 1 Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Indicated Change From Baseline in the EC Grading Scale at 2 Years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cellular proliferation assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants with Reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: 24hr. voiding diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From 0 to 24 Hours (AUC0-24) of Doravirine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Doravirine at 24 Hours (C24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Rate of Microscopic pCR and Macroscopic Pathologic Complete Response (mCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the concentration-time curve from time of dosing to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients with BP <140/90 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: consumption of propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-procedure pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time of use of topical corticosteroids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Variation in SCORAD score during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained symptomatic response (SSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elasticity score of lung parenchyma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Strain index of lung parenchyma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perioperative anxiety level of children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Recruitment Rate Per Center Per Month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 1-year PFS2 Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With All Non-serious Adverse Events (AEs) and Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Complete recanalization percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of tests taken
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in periapical lesion diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of sedative infused
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of endoscopy for Barrett's esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cardiac death or readmission for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Parameters of cardiac conduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in PPD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in PBMC-IFN gamma-alpha 1(II)/PBS stimulation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post-mastectomy pain syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Validity of intra-operative intracavitary ultrasound for localization of pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of liver steatosis parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of liver fibrosis parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Medical Errors
Endpoint domain: Adverse events/effects
Primary endpoint: Survivorship of the device
Endpoint domain: Mortality/survival
Primary endpoint: Minimal transverse airway Diameter (MTAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ancestry percentage difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants deciding to resuscitate an extremely premature infant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Wound epithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnostic accuracy of MYB expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cerebral activity in food intake inhibition control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Carnitine Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Oxygen Level-dependent (BOLD) fMRI Response to Food-specific Stop-signal Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Oxygen Level-dependent (BOLD) fMRI Response to Binge-eating Script-driven Imagery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the proportion of Children receiving Minimum Acceptable Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pupillary diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of acute diverticulitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Systemic inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faecal calprotectine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Local inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients needing opioids in recovery room
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients Progression-free at Least One Year
Endpoint domain: Mortality/survival
Primary endpoint: Change in the Abundance of Staphylococcus Aureus in the Nose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in the Abundance of Staphylococcus Aureus in the Throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severe brain injury or death
Endpoint domain: Mortality/survival
Primary endpoint: Plasma concentrations of JNJ-39439335
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine concentrations of JNJ-39439335
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EULAR Therapeutic Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy Clinical Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barnes Akathesia Scale (BAS)
Endpoint domain: Adverse events/effects
Primary endpoint: Simpson-Angus Scale (SAS)
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal Involuntary Movement Scale (AIMS)
Endpoint domain: Adverse events/effects
Primary endpoint: Response Rate (Complete Response, Unconfirmed Complete Response, and Partial Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EFS
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Root Canal Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall frequency of favourable clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall frequency of unfavourable clinical outcome or death
Endpoint domain: Mortality/survival
Primary endpoint: number of swallows during feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral performance (accuracy, or rate of conditioned responses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Local Adverse Reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of closed skin ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants with clinical progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of prescriptions for NRT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diffuse myocardial fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: freedom-from-relapse
Endpoint domain: Mortality/survival
Primary endpoint: Change in submental skin laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Occurrence, severity, and relatedness of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Canadian Occupational Performance Measure (COPM) change
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient-Reported Outcomes Measurement Information System-Global Health (PROMIS-G)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pittsburgh Sleep Quality Index (PSQI) change
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Multidimensional Assessment of Fatigue Scale (MAF) change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Subjects' Perception at Insertion of Test Catheter Activated for 5 Seconds
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjects' Perception at Insertion of Test Catheter Activated for 24 Hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjects' Perception at Withdrawal of Test Catheter Activated for 5 Seconds
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjects' Perception at Withdrawal of Test Catheter Activated for 24 Hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global response assessment scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Parkinson's Disease symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation difficulty scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of treatment induced dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Grade of treatment induced DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of treatment emergent AEs (adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: aEEG voltage amplitude changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apnea Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Severe Asthma Exacerbations During the Treatment Period
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Albumin and Total Protein at Week 12, Week 28, and Week 52/Early Withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With at Least 30% Improvement in NRS Average Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migration of the screw
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Telescoping of the femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ultrasonographic endometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Oxygen Uptake (V'O2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 10-meter walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Timed up and go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activities-specific Balance Confidence (ABC) Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in The Berg Balance Scale (BBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time CGM glucose is <70mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Timeline Followback of Substance Use (TLFB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes